Star Combo Pharma Limited

ASX:S66 株式レポート

時価総額:AU$16.2m

Star Combo Pharma マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Su Zhang

最高経営責任者

AU$209.7k

報酬総額

CEO給与比率90.1%
CEO在任期間6.8yrs
CEOの所有権8.5%
経営陣の平均在職期間データなし
取締役会の平均在任期間6.8yrs

経営陣の近況

Recent updates

Some Star Combo Pharma Limited (ASX:S66) Shareholders Look For Exit As Shares Take 31% Pounding

Nov 11
Some Star Combo Pharma Limited (ASX:S66) Shareholders Look For Exit As Shares Take 31% Pounding

Star Combo Pharma Limited's (ASX:S66) 30% Share Price Surge Not Quite Adding Up

Aug 23
Star Combo Pharma Limited's (ASX:S66) 30% Share Price Surge Not Quite Adding Up

Star Combo Pharma (ASX:S66) Might Have The Makings Of A Multi-Bagger

Aug 13
Star Combo Pharma (ASX:S66) Might Have The Makings Of A Multi-Bagger

Star Combo Pharma Limited's (ASX:S66) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Jun 12
Star Combo Pharma Limited's (ASX:S66) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Star Combo Pharma (ASX:S66) Is Doing The Right Things To Multiply Its Share Price

May 12
Star Combo Pharma (ASX:S66) Is Doing The Right Things To Multiply Its Share Price

Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon

Mar 20
Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon

Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Nov 21
Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think

Mar 02
Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think

Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt

Dec 24
Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt

CEO報酬分析

Star Combo Pharma の収益と比較して、Su Zhang の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024AU$210kAU$189k

AU$747k

Mar 31 2024n/an/a

AU$616k

Dec 31 2023n/an/a

AU$485k

Sep 30 2023n/an/a

-AU$2m

Jun 30 2023AU$196kAU$170k

-AU$4m

Mar 31 2023n/an/a

-AU$5m

Dec 31 2022n/an/a

-AU$5m

Sep 30 2022n/an/a

-AU$3m

Jun 30 2022AU$194kAU$172k

-AU$696k

Mar 31 2022n/an/a

-AU$5m

Dec 31 2021n/an/a

-AU$8m

Sep 30 2021n/an/a

-AU$8m

Jun 30 2021AU$182kAU$163k

-AU$8m

Mar 31 2021n/an/a

-AU$3m

Dec 31 2020n/an/a

AU$1m

Sep 30 2020n/an/a

AU$533k

Jun 30 2020AU$169kAU$153k

-AU$349k

Mar 31 2020n/an/a

-AU$990k

Dec 31 2019n/an/a

-AU$2m

Sep 30 2019n/an/a

-AU$2m

Jun 30 2019AU$164kAU$150k

-AU$2m

Mar 31 2019n/an/a

-AU$2m

Dec 31 2018n/an/a

-AU$3m

Sep 30 2018n/an/a

-AU$2m

Jun 30 2018AU$93kAU$85k

-AU$2m

報酬と市場: Suの 総報酬 ($USD 135.39K ) は、 Australian市場 ($USD 295.69K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Suの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Su Zhang

6.8yrs

在職期間

AU$209,701

報酬

Ms. Su Zhang, MBA, GradCertComm, BPharm serves as Chief Executive Officer at Star Combo Pharma Ltd since November 2018 and serves as its Executive Director since 2018. She served as Director at Star Combo...


取締役

名称ポジション在職期間報酬所有権
Su Zhang
CEO & Executive Director6.8yrsAU$209.70k8.48%
A$ 1.4m
JinXing Zhang
Founder8yrsAU$199.83k28.25%
A$ 4.6m
Richard Allely
Independent Non-Executive Chairman6.8yrsAU$101.37kデータなし
Wei Han
Non Executive Director4.5yrsデータなしデータなし
Jialong Ding
Non Executive Director4.5yrsデータなしデータなし

6.8yrs

平均在職期間

経験豊富なボード: S66の 取締役会経験豊富 であると考えられます ( 6.8年の平均在任期間)。